IGFBP7 and hepatocellular carcinoma: This peptide is downregulated in hepatocellular carcinoma lesions, compared with its expression in adjacent healthy tissue [19], and in IGFBP-7-deficient mice, the spontaneous development of liver tumors is observed [46].